X-137566825-ACGCCGCCGCCGCCGC-ACGCCGC
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP3BP6_ModerateBS2
The NM_003413.4(ZIC3):βc.153_161delβ(p.Ala53_Ala55del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000669 in 1,160,670 control chromosomes in the GnomAD database, including 1 homozygotes. There are 229 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (β ).
Frequency
Genomes: π 0.00072 ( 0 hom., 23 hem., cov: 24)
Exomes π: 0.00066 ( 1 hom. 206 hem. )
Consequence
ZIC3
NM_003413.4 inframe_deletion
NM_003413.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.41
Genes affected
ZIC3 (HGNC:12874): (Zic family member 3) This gene encodes a member of the ZIC family of C2H2-type zinc finger proteins. This nuclear protein probably functions as a transcription factor in early stages of left-right body axis formation. Mutations in this gene cause X-linked visceral heterotaxy, which includes congenital heart disease and left-right axis defects in organs. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_003413.4
BP6
Variant X-137566825-ACGCCGCCGC-A is Benign according to our data. Variant chrX-137566825-ACGCCGCCGC-A is described in ClinVar as [Benign]. Clinvar id is 464970.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 23 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZIC3 | NM_003413.4 | c.153_161del | p.Ala53_Ala55del | inframe_deletion | 1/3 | ENST00000287538.10 | NP_003404.1 | |
ZIC3 | NM_001330661.1 | c.153_161del | p.Ala53_Ala55del | inframe_deletion | 1/3 | NP_001317590.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZIC3 | ENST00000287538.10 | c.153_161del | p.Ala53_Ala55del | inframe_deletion | 1/3 | 1 | NM_003413.4 | ENSP00000287538 | P1 | |
ZIC3 | ENST00000370606.3 | c.153_161del | p.Ala53_Ala55del | inframe_deletion | 1/3 | 5 | ENSP00000359638 |
Frequencies
GnomAD3 genomes AF: 0.000734 AC: 82AN: 111758Hom.: 0 Cov.: 24 AF XY: 0.000674 AC XY: 23AN XY: 34144
GnomAD3 genomes
AF:
AC:
82
AN:
111758
Hom.:
Cov.:
24
AF XY:
AC XY:
23
AN XY:
34144
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000829 AC: 80AN: 96477Hom.: 0 AF XY: 0.000921 AC XY: 30AN XY: 32583
GnomAD3 exomes
AF:
AC:
80
AN:
96477
Hom.:
AF XY:
AC XY:
30
AN XY:
32583
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000664 AC: 696AN: 1048869Hom.: 1 AF XY: 0.000603 AC XY: 206AN XY: 341511
GnomAD4 exome
AF:
AC:
696
AN:
1048869
Hom.:
AF XY:
AC XY:
206
AN XY:
341511
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000725 AC: 81AN: 111801Hom.: 0 Cov.: 24 AF XY: 0.000673 AC XY: 23AN XY: 34197
GnomAD4 genome
AF:
AC:
81
AN:
111801
Hom.:
Cov.:
24
AF XY:
AC XY:
23
AN XY:
34197
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Heterotaxy, visceral, 1, X-linked Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 12, 2020 | - - |
ZIC3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 29, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at